FDA Calls for More Restrictions on Fluoroquinolone Use (FREE)

By Kristin J. Kelley Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH The risks for "disabling and potentially permanent" side effects associated with systemic fluoroquinolone antibacterials (e.g., ciprofloxacin, moxifloxacin) generally outweigh the benefits in patients with …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news